Following the seminal discovery of insulin a century ago, treatment of individuals with type 1
diabetes (T1D) has been largely restricted to efforts to monitor and treat metabolic glucose …

Autoimmune diseases are a diverse and complex set of chronic disorders with a substantial
impact on patient quality of life and a significant global healthcare burden. Current …

Background The association of COVID-19 with the development of new-onset diabetes has
been recently investigated by several groups, yielding controversial results. Population …

Introduction The coronavirus disease 2019 (COVID-19) pandemic became superimposed
on the pre-existing obesity and diabetes mellitus (DM) pandemics. Since COVID-19 infection …

Background Some studies have shown that the incidence of type 2 diabetes increases after
a diagnosis of COVID-19, although the evidence is not conclusive. However, the effects of …

Aims/hypothesis Type 1 diabetes is an heterogenous condition. Characterising factors
explaining differences in an individual's clinical course and treatment response will have …

We previously reported in Diabetes Care (1) that the incidence of type 1 diabetes among
children aged 0–14 years in Scotland during 2020–2021 was 20% higher than the 7-year …

In a systematic review and meta-analysis in JAMA Network Open, D'Souza et al1 compared
changes in the incidence of diabetes (type 1 and type 2) and the proportion of diabetic …

Environmental factors, in particular viral infections, are thought to have an important role in
the pathogenesis of type 1 diabetes mellitus (T1DM). The COVID-19 pandemic reinforced …

Aim. To assess the incidence trends in type 1 diabetes among children and adolescents
across Europe during the period from 1994 to 2022 using a systematic methodology …